Overview:

​

Our company is currently working on innovative DNA vaccine against SARS-CoV-2 on the base of our DNA vectors, encoding immunogenic epitopes of SARS-CoV-2 proteins.

​

Our latest achievements:

1. Created prototypes of the DNA vaccine

2. Produced E.coli strains for DNA vaccine development on a commercial scale

3. Completed a package of international patent procedures (p. a. No20200113297, W20022443)

4. Completed in vitro studies that show the efficiency of the vaccine

5. At the moment, preclinical studies on animals are being carried out to evaluate the pharmacological activity of the DNA vaccine and its safety

​

DNA Vaccination Advantages:

​

The advantages of DNA vaccination include:

1. Ensuring not only the production of antibodies (humoral immunity), but a specific cytotoxic T-cell response (cell-mediated immunity)

2. Activation of cytotoxic T-cells without injecting a living pathogen

3. Antigens expression in the native conformation

​

Gene-therapy DNA vectors that are present in the DNA vaccine:

​

The developed gene-therapy DNA vectors, being a part of the DNA vaccine, comply with the strictest modern regulatory requirements for effectiveness and safety.

​

Other advantages of our gene-therapy vectors:

     - Elimination of emergence and spread of antibiotic resistance microorganisms (the DNA vectors do not contain antibiotic resistance genes);

     - Elimination of a spontaneous induction of oncotransformation (the DNA vectors do not contain regulatory sequences of viral genomes)

​

Partnerships & Alliances:

​

Drawing on our advantages, and, also, taking into account the numerous alternative versions of vaccines against SARS-CoV-2 announced by various developers and pharmaceutical companies, we assess the probability of successful tests and the launch of our DNA vaccine against SARS-CoV-2 onto the market as very high.

​

    - We are currently looking to build alliances & partnerships with potential investors to promote our clinical research and prepare for a potential launch onto market.

     - If you are interested in this opportunity, please use our contact form here.